Search Results - "Sjöström, D."

Dapagliflozin reduces albuminuria in patients with diabetes and hypertension receiving renin-angiotensin blockers by Heerspink, H. J. L., Johnsson, E., Gause-Nilsson, I., Cain, V. A., Sjöström, C. D.

“…Aims To characterize the effect of dapagliflozin on albuminuria and estimated glomerular filtration rate (eGFR) and to determine whether effects on albuminuria…”
Get full text

Incidence of end-stage renal disease following bariatric surgery in the Swedish Obese Subjects Study by Shulman, A., Peltonen, M., Sjöström, C. D., Andersson-Assarsson, J. C., Taube, M., Sjöholm, K., le Roux, C. W., Carlsson, L. M. S., Svensson, P.-A.

“…Background Obesity is a major public health problem leading to co-morbidities such as diabetes, hypertension and kidney failure. Bariatric surgery results in…”
Get full text

Impact of weight change, secular trends and ageing on cardiovascular risk factors: 10-year experiences from the SOS study by Sjöström, C.D, Lystig, T, Lindroos, A.K

“…Objective: Many short-term studies indicate that 5% weight loss in the obese is enough to induce significant improvements of cardiovascular risk factors…”
Get full text

Dosimetric and geometric evaluation of the use of deformable image registration in adaptive intensity-modulated radiotherapy for head-and-neck cancer by Eiland, R.B., Maare, C., Sjöström, D., Samsøe, E., Behrens, C.F.

“…The aim of this study was to carry out geometric and dosimetric evaluation of the usefulness of a deformable image registration algorithm utilized for adaptive…”
Get full text

Changes in weight loss-related quality of life among type 2 diabetes mellitus patients treated with dapagliflozin by Grandy, S., Hashemi, M., Langkilde, A.-M., Parikh, S., Sjöström, C. D.

“…Aims This study evaluated change in health‐related quality of life (HRQOL) associated with ongoing weight change among patients with type 2 diabetes mellitus…”
Get full text

PO-0886: Does lung capacity influence the geometrical reproducibility in DIBH radiotherapy of NSCLC patients? by Sibolt, P, Ottosson, W, Behrens, C.F, Sjöström, D

Get full text

Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin by Bolinder, J., Ljunggren, Ö., Johansson, L., Wilding, J., Langkilde, A. M., Sjöström, C. D., Sugg, J., Parikh, S.

“…Aims Dapagliflozin, a highly selective inhibitor of sodium‐glucose cotransporter 2 (SGLT2), reduces hyperglycaemia and weight in patients with type 2 diabetes…”
Get full text

EP-1549: Evaluation of a commercially available software for 3D dose and delivery verification of radiation treatment plans by Sibolt, P, Bjelkengren, U, Buhl, S.K, Sjöström, D, Behrens, C.F

Get full text

PD-0273 DOSIMETRIC CONSEQUENCES DUE TO TUMOUR SHRINKAGE AND WEIGHT LOSS FOR IMRT AND RA TREATMENT PLANNING by Elezaj, D, Pohl, Z.P, Behrens, C.F, Sjöström, D

Get full text

PD-0271: Dosimetric consequences due to shoulder position and how to increase the robustness for VMAT treatment planning by Pohl, Z, Sjölin, M, Samsøe, E, Behrens, C.F, Sjöström, D

Get full text

PO-0865: Quantitative clinical image quality comparison of pelvic CBCT for two imaging systems by Andreasen, T.B, Lindberg, H, Sjöström, D, Vestergaard, A, Behrens, C.F

Get full text

SU‐E‐T‐104: Utilizing Statistical Process Control and EPID for Routine QA of Medical Linear Accelerators by Andersson, P, Bjelkengren, U, Sjöström, D, Behrens, C

“…Purpose: To investigate the suitability of an aSi EPID as a dosimetric quality assurance device. Action thresholds are obtained using statistical process…”
Get full text

Self-reported sleep apnoea and mortality in patients from the Swedish Obese Subjects study by MARSHALL, N. S, DELLING, L, GRUNSTEIN, R. R, PELTONEN, M, SJÖSTRÖM, C. D, KARASON, K, CARLSSON, L. M. S, HEDNER, J, STENLÖF, K, SJÖSTRÖM, L

“…Sleep apnoea is associated with increased mortality in sleep clinic and community population groups. It is unclear whether a clinical report of sleep apnoea…”
Get full text

Adaptive RT for Head-and-Neck Cancer: The Usefulness of Deformable Image Registration by Behrens, C.F, Eiland, R.B, Sjöström, D, Maare, C, Paulsen, R.R, Samsøe, E

Get full text

EP-1599 HOW TO ENSURE CONSISTENT, PRECISE AND SAFE DELIVERY AF ORTHOVOLTAGE X-RAY TREATMENTS by Thrane, V, Bodker, L, Sjöström, D, Behrens, C, Schnoor, P

Get full text

OC-0467 THE IMPACT OF THE MLC MODELING FOR IMRT AND VMAT ON A PATIENT SPECIFIC LEVEL by Sjölin, M, Edmund, J.M, Bjelkengren, U, Sjöström, D, Behrens, C.F

Get full text

479 poster EVALUATION OF VISABILITY OF BOTH LOW AND HIGH DENSITY FIDUCIAL MARKERS ON MR, CT, CBCT AN KV IMAGES by Kristensen, B. Holch, Hansen, R.H, Sjöberg, J, Sjöström, D

Get full text

PO-0893 DOSIMETRIC- AND GEOMETRIC EVALUATION OF ADAPTIVE H&N IMRT USING DEFORMABLE IMAGE REGISTRATION by Eiland, R.B, Behrens, C.F, Sjöström, D, Maare, C, Paulsen, R.R, Samsoe, E

Get full text

Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin by Ljunggren, Ö., Bolinder, J., Johansson, L., Wilding, J., Langkilde, A. M., Sjöström, C. D., Sugg, J., Parikh, S.

“…Aims Dapagliflozin, a selective sodium‐glucose cotransporter 2 (SGLT2) inhibitor, reduces hyperglycaemia in patients with type 2 diabetes (T2DM) by increasing…”
Get full text

PD-0356 DEVELOP AND IMPLEMENTING A CANCER TYPE SPECIFIC EDUCATIONAL PROGRAM FOR IMAGE MATCHING by Sjöström, D, Buhl, S.K, Baker, M, Andersen, K, Dinesen, N. Hviid, Lind, S, Valentin, S, Behrens, C.F, Brandhof, V

Get full text